Parkwood Institute, Lawson Health Research Institute, London, Canada.
Department of Physical Medicine and Rehabilitation, Schulich School of Medicine and Dentistry, Western University, London, Canada.
J Spinal Cord Med. 2024 Jul;47(4):465-476. doi: 10.1080/10790268.2023.2218186. Epub 2023 Jul 10.
Neuropathic pain is a common and debilitating condition following SCI. While treatments for neuropathic pain intensity have been reviewed, the impact on pain interference has not been summarized.
To systematically review the effect of neuropathic pain interventions on pain interference in individuals with spinal cord injury.
This systematic review included randomized controlled trials and quasi-experimental (non-randomized) studies which assessed the impact of an intervention on pain interference in individuals with spinal cord injury and neuropathic pain. Articles were identified by searching MEDLINE (1996 to April 11, 2022), EMBASE (1996 to April 11, 2022), PsycInfo (1987 to April, week 2, 2022). Studies were assessed for methodologic quality using a modified GRADE approach and were given quality of evidence (QOE) scores on a 4-point scale ranging from very low to high.
Twenty studies met the inclusion criteria. These studies fell into the following categories: anticonvulsants ( = 2), antidepressants ( = 1), analgesics ( = 1), antispasmodics ( = 1), acupuncture ( = 2), transcranial direct current stimulation ( = 1), active cranial electrotherapy stimulation ( = 2), transcutaneous electrical nerve stimulation ( = 2), repetitive transcranial magnetic stimulation ( = 1), functional electrical stimulation ( = 1), meditation and imagery ( = 1), self-hypnosis and biofeedback ( = 1), and interdisciplinary pain programs ( = 4).
When considering studies of moderate to high quality, pregabalin, gabapentin, intrathecal baclofen, transcranial direct current stimulation, and transcutaneous electrical nerve stimulation (in 1 of 2 studies) were shown to have beneficial effects on pain interference. However, due to the low number of high-quality studies further research is required to confirm the efficacy of these interventions prior to recommending their use to reduce pain interference.
神经性疼痛是 SCI 后的一种常见且使人虚弱的病症。虽然已经对神经性疼痛强度的治疗方法进行了综述,但尚未总结其对疼痛干扰的影响。
系统评价神经性疼痛干预对脊髓损伤患者疼痛干扰的影响。
本系统评价纳入了评估干预对神经性疼痛脊髓损伤患者疼痛干扰影响的随机对照试验和准实验(非随机)研究。通过检索 MEDLINE(1996 年至 2022 年 4 月 11 日)、EMBASE(1996 年至 2022 年 4 月 11 日)和 PsycINFO(1987 年至 2022 年 4 月,第 2 周)来确定文章。使用改良 GRADE 方法评估研究的方法学质量,并根据 4 分制(从极低到高)对证据质量(QOE)评分。
符合纳入标准的研究有 20 项。这些研究分为以下几类:抗惊厥药(=2)、抗抑郁药(=1)、镇痛药(=1)、抗痉挛药(=1)、针刺(=2)、经颅直流电刺激(=1)、主动颅电刺激(=2)、经皮神经电刺激(=2)、重复经颅磁刺激(=1)、功能性电刺激(=1)、冥想和意象(=1)、自我催眠和生物反馈(=1)以及跨学科疼痛方案(=4)。
当考虑到具有中等到高质量的研究时,普瑞巴林、加巴喷丁、鞘内巴氯芬、经颅直流电刺激和经皮神经电刺激(在 2 项研究中的 1 项中)显示对疼痛干扰有有益影响。然而,由于高质量研究的数量较少,需要进一步研究以确认这些干预措施的疗效,然后才能推荐用于减轻疼痛干扰。